TY - JOUR
T1 - Do Myelin Oligodendrocyte Glycoprotein Antibodies Represent a Distinct Syndrome?
AU - Chen, John J.
AU - Fraser, Clare L.
N1 - Publisher Copyright:
© 2019 Lippincott Williams and Wilkins. All rights reserved.
PY - 2019/9/1
Y1 - 2019/9/1
N2 - Myelin oligodendrocyte glycoprotein (MOG-IgG) antibodies have been associated with a variety of demyelinating neurologic disorders, including optic neuritis. It remains unclear whether the presence of MOG-IgG represents a distinct syndrome or is simply a marker for central demyelination. Two experts, John J. Chen, MD, PhD, and Clare L. Fraser, MBBS, MMed, debate this topic.
AB - Myelin oligodendrocyte glycoprotein (MOG-IgG) antibodies have been associated with a variety of demyelinating neurologic disorders, including optic neuritis. It remains unclear whether the presence of MOG-IgG represents a distinct syndrome or is simply a marker for central demyelination. Two experts, John J. Chen, MD, PhD, and Clare L. Fraser, MBBS, MMed, debate this topic.
UR - http://www.scopus.com/inward/record.url?scp=85071510547&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85071510547&partnerID=8YFLogxK
U2 - 10.1097/WNO.0000000000000779
DO - 10.1097/WNO.0000000000000779
M3 - Article
C2 - 30865056
AN - SCOPUS:85071510547
VL - 39
SP - 416
EP - 423
JO - Journal of Clinical Neuro-Ophthalmology
JF - Journal of Clinical Neuro-Ophthalmology
SN - 1070-8022
IS - 3
ER -